A Promising Future for Prostate Cancer Diagnostics
AbstractIt has been estimated that globally there is a death attributable to prostate cancer every four minutes. As life expectancy in all world regions increases, so too incidence of this disease of the ageing male will increase. For many men diagnosis occurs after presentation with symptoms of altered urinary dynamics. Unfortunately, these changes, whilst also associated with benign disease, are evident quite late in the aetiology of prostate cancer. Early detection provides for better management and prognosis. This Special Issue provides an up to date view of the advances made towards early diagnosis and prognosis. It provides reviews of advanced imaging techniques (e.g., multiparametric MRI and protocols), and of biomaterials and molecular biomarkers currently being explored (e.g., microRNAs, proteomics) and the technologies that are revolutionizing this field. It describes the multi-disciplinary approaches that are essential to inexpensive, deliverable and accurate platforms for prostate cancer diagnostics. View Full-Text
Share & Cite This Article
Assinder, S.J.; Bhoopalan, V. A Promising Future for Prostate Cancer Diagnostics. Diagnostics 2017, 7, 6.
Assinder SJ, Bhoopalan V. A Promising Future for Prostate Cancer Diagnostics. Diagnostics. 2017; 7(1):6.Chicago/Turabian Style
Assinder, Stephen J.; Bhoopalan, Vanitha. 2017. "A Promising Future for Prostate Cancer Diagnostics." Diagnostics 7, no. 1: 6.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.